17α-Estradiol is neuroprotective in male and female rats in a model of early brain injury

Experimental Neurology

Volumn 210, Issue 1, 2008, Pages 41-50

  McClean, Jacob ^a   Nuñez, Joseph L ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Development; Fetal alcohol; GABA; Hippocampus; Hypoxia ischemia; Seizures; Steroid hormones

Indexed keywords

17ALPHA ESTRADIOL; ALCOHOL; BARBITURIC ACID DERIVATIVE; ESTRADIOL; FULVESTRANT; SESAME SEED OIL; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTIESTROGEN; DRUG DERIVATIVE; LACTATE DEHYDROGENASE; MUSCIMOL; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SIZE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; ENZYME ASSAY; FEMALE; GABAERGIC SYSTEM; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MAZE TEST; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SEIZURE; WORKING MEMORY; ANALYSIS OF VARIANCE; ANIMAL; ANIMAL BEHAVIOR; CYTOLOGY; DISEASE MODEL; METABOLISM; NERVE CELL; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; SEX DIFFERENCE; SPRAGUE DAWLEY RAT; TIME;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN INJURIES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; GABA AGONISTS; HIPPOCAMPUS; IN SITU NICK-END LABELING; L-LACTATE DEHYDROGENASE; MALE; MAZE LEARNING; MUSCIMOL; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; TIME FACTORS;

EID: 39149107843     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.09.027     Document Type: Article

References (43)

1. Amateau S.K., Alt J.J., Stamps C.L., and McCarthy M.M. Brain estradiol content in newborn rats: sex differences in regional heterogeneity, and possible de novo synthesis by the female telencephalon. Endocrinology 145 (2004) 2906-2917
2. Arnold A.P., and Gorski R.A. Gonadal steroid induction of structural sex differences in the central nervous system. Annu. Rev. Neurosci. 7 (1984) 413-442
3. Behl C., Widmann M., Trapp T., and Holsboer F. 17-beta Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216 (1995) 473-482
4. Cordey M., and Pike C.J. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons. Brain Res. 1045 (2005) 217-223
5. Culmsee C., Vedder H., Ravati A., Junker V., Otto D., Ahlemeyer B., Krieg J.C., and Krieglstein J. Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism. J. Cereb. Blood Flow Metab. 19 (1999) 1263-1269
6. Dubal D.B., Shughrue P.J., Wilson M.E., Merchenthaler I., and Wise P.M. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 19 (1999) 6385-6393
7. Dubal D.B., Rau S.W., Shughrue P.J., Zhu H., Yu J., Cashion A.B., Suzuki S., Gerhold L.M., Bottner M.B., Dubal S.B., Merchanthaler I., Kindy M.S., and Wise P.M. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death. Endocrinology 147 (2006) 3076-3084
8. Finkelstein M., Weidenfeld J., Ne'eman Y., Samuni A., Mizrachi Y., and Ben-Uzilio R. Comparative studies of the aromatization of testosterone and epitestosterone by human placenta aromatase. Endocrinology 108 (1981) 943-947
9. Flint A.P., and Burrow P.V. Epitestosterone in the plasma of the goat during pregnancy and at parturition. J. Endocrinol. 82 (1979) 287-291
10. Green P.S., Bishop J., and Simpkins J.W. 17 alpha-Estradiol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci. 17 (1997) 511-515
11. Green P.S., Yang S.H., Nilsson K.R., Kumar A.S., Covey D.F., and Simpkins J.W. The nonfeminizing enantiomer of 17beta-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia. Endocrinology 142 (2001) 400-406
12. Hammond J., Le Q., Goodyer C., Gelfand M., Trifiro M., and LeBlanc A. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J. Neurochem. 77 (2001) 1319-1326
13. Harms C., Lautenschlager M., Bergk A., Katchanov J., Freyer D., Kapinya K., Herwig U., Megow D., Dirnagl U., Weber J.R., and Hortnagl H. Differential mechanisms of neuroprotection by 17 beta-estradiol in apoptotic versus necrotic neurodegeneration. J. Neurosci. 21 (2001) 2600-2609
14. Havlikova H., Hill M., Hampl M., and Starka L. Sex- and age-related changes in epitestosterone in relation to pregnenolone sulfate and testosterone in normal subjects. J. Clin. Endocrinol. Metab. 87 (2002) 2225-2231
15. Higuchi T., and Villee C.A. Aromatization of epitestosterone by human placenta. Endocrinology 86 (1970) 912-913
16. Hilton G.D., Bambrick L.L., Thompson S.M., and McCarthy M.M. Estradiol modulation of kinainic acid-induced calcium elevation in neuronal hippocampal neurons. Endocrinology 147 (2006) 1246-1255
17. Honda K., Sawada H., Kihara T., Urushitani M., Nakamizo T., Akaike A., and Shimohama S. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J. Neurosci. Res. 60 (2000) 321-327
18. Horn H., and Finkelstein M. Aromatization of epitestosterone by human placenta. Endocrinology 88 (1971) 271-273
19. Huang Y., Huang Y.L., Zhang S., Zhu Y.C., and Yao T. Estradiol acutely attenuates glutamate-induced calcium overload in primarily cultured rat hippocampal neurons through a membrane receptor-dependent mechanism. Brain Res. 1026 (2004) 254-260
20. Jover T., Tanaka H., Calderone A., Oguro K., Bennett M.V., Etgen A.M., and Zukin R.S. Estrogen protects against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1. J. Neurosci. 22 (2002) 2115-2124
21. Linford N., Wade C., and Dorsa D. The rapid effects of estrogen are implicated in estrogen-mediated neuroprotection. J. Neurocytol. 29 (2000) 367-374
22. MacLusky N.J., and Naftolin F. Sexual differentiation of the central nervous system. Science 211 (1981) 294-302
23. McEwen B.S. Neural gonadal steroid actions. Science 211 (1981) 1303-1311
24. Mize A.L., Shapiro R.A., and Dorsa D.M. Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology 144 (2003) 306-312
25. Nunez J.L., and McCarthy M.M. Estradiol exacerbates hippocampal damage in a model of preterm infant brain injury. Endocrinology 144 (2003) 2350-2359
26. Nunez J.L., Bambrick L.L., Krueger B.K., and McCarthy M.M. Prolongation and enhancement of gamma-aminobutyric acid receptor mediated excitation by chronic treatment with estradiol in developing rat hippocampal neurons. Eur. J. Neurosci. 21 (2005) 3251-3261
27. Nuñez J.L., Alt J.J., and McCarthy M.M. A new model for prenatal brain damage: I. GABAA receptor activation induces cell death in developing rat hippocampus. Exp. Neurol. 181 (2003) 258-269
28. Nuñez J.L., Alt J.J., and McCarthy M.M. A novel model for prenatal brain damage: II. Long-term deficits in hippocampal cell number and hippocampal-dependent behavior following neonatal GABAA receptor activation. Exp. Neurol. 181 (2003) 270-280
29. Perrella J., and Bhavnani B.R. Protection of cortical cells by equine estrogens against glutamate-induced excitotoxicity is mediated through a calcium independent mechanism. BMC Neurosci. 6 (2005) 34
30. Prokai L., Prokai-Tatrai K., Perjesi P., Zharikova A.D., Perez E.J., Liu R., and Simpkins J.W. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 11741-11746
31. Simpkins J.W., Rajakumar G., Zhang Y.Q., Simpkins C., Greenwald D., Yu C.J., Bodor N., and Day A.L. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87 (1997) 724-730
32. Singer C.A., Rogers K.L., and Dorsa D.M. Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport 9 (1998) 2565-2568
33. Singh M., Setalo Jr.G., Guan X., Warren M., and Toran-Allerand C.D. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J. Neurosci. 19 (1999) 1179-1188
34. Starka L. Epitestosterone. J. Steroid Biochem. Mol. Biol. 87 (2003) 27-34
35. Stoltzner S.E., Berchtold N.C., Cotman C.W., and Pike C.J. Estrogen regulates bcl-x expression in rat hippocampus. Neuroreport 12 (2001) 2797-2800
36. Toran-Allerand C.D., Tinnikov A.A., Singh R.J., and Nethrapalli I.S. 17alpha-Estradiol: a brain-active estrogen?. Endocrinology 146 (2005) 3843-3850
37. Toung T.J., Traystman R.J., and Hurn P.D. Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 29 (1998) 1666-1670
38. Veliskova J., Velisek L., Galanopoulou A.S., and Sperber E.F. Neuroprotective effects of estrogens on hippocampal cells in adult female rats after status epilepticus. Epilepsia 6 (2000) S30-S35
39. Volpe J.J. Perinatal brain injury: from pathogenesis to neuroprotection. Ment. Retard. Dev. Disabil. Res. Rev. 7 (2001) 56-64
40. 2 toxicity in human neuroblastoma SK-N-SH cells. Mol. Pharmacol. 70 (2006) 395-404
41. Zhao L., and Brinton R.D. Select estrogens within the complex formation of conjugated equines estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. BMC Neurosci. 7 (2006) 1-13
42. Zhao L., Wu T.W., and Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 1010 (2004) 22-34
43. Zhao L., Chen S., Ming Wang J., and Brinton R.D. 17beta-estradiol induces Ca(2+) influx, dendritic and nuclear Ca(2+) rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: a potential initiation mechanism for estrogen neurotrophism. Neuroscience 132 (2005) 299-311